The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Abstract
In vitro, when the B7 molecule on the surface of antigen-presenting cells binds to the T cell surface molecules CD28 and CTLA-4, a costimulatory signal for T cell activation is generated. CTLA4Ig is a soluble form of the extracellular domain of CTLA-4 and binds B7 with high avidity. CTLA4Ig treatment in vivo suppressed T cell-dependent antibody responses to sheep erythrocytes or keyhole limpet hemocyanin. Large doses of CTLA4Ig suppressed responses to a second immunization. Thus, costimulation by B7 is important for humoral immune responses in vivo, and interference with costimulation may be useful for treatment of antibody-mediated autoimmune disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Self-citationIdentification of a monoclonal antibody specific for a murine T3 polypeptide.
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1374 · Cited by 1,593
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,493
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Self-citationLong-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
Self-citationT-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley, P. S., Clark, E. A., & Ledbetter, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5031 · Cited by 747
Self-citationSpecific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1
Isobe, M., Yagita, H., Okumura, K., & Ihara, A. (1992) · Science · doi:10.1126/science.1347662 · Cited by 715
Cited by
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Self-citationKuchroo, V. K., Prabhu Das, M., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., & Glimcher, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90349-6 · Cited by 1,641
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Elgueta, R., Benson, M. J., De Vries, V. C., Wasiuk, A., Guo, Y., & Noelle, R. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00782.x · Cited by 1,625
Yu, X., Harden, K., C Gonzalez, L., Francesco, M., Chiang, E., Irving, B., Tom, I., Ivelja, S., Refino, C. J., Clark, H., et al. (2009) · Nature Immunology · doi:10.1038/ni.1674 · Cited by 1,491
Immune Checkpoint Inhibitors in Cancer Therapy
Shiravand, Y., Khodadadi, F., Kashani, S. M. A., Hosseini-Fard, S. R., Hosseini, S., Sadeghirad, H., Ladwa, R., O’Byrne, K., & Kulasinghe, A. (2022) · Current Oncology · doi:10.3390/curroncol29050247 · Cited by 1,353
“Despite the fact that CTLA-4 binds to the same ligand B7 on B cells and APCs as its homologue CD28, stimulation of CTLA-4 resulted to T cell-mediated suppression of antibody formation and avoidance of allograft rejection [75,76].”
BackgroundThe Role of the CD28 Receptor During T Cell Responses to Antigen
Linsley, P. S., & Ledbetter, J. A. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001203 · Cited by 1,298
Self-citationThe B7 and CD28 receptor families
June, C. H., Bluestone, J. A., Nadler, L. M., & Thompson, C. B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90080-9 · Cited by 1,296
Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
Self-citationChen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
Self-citationComplexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006
Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., & Peach, R. (1994) · Immunity · doi:10.1016/s1074-7613(94)80021-9 · Cited by 980
Self-citationB70 antigen is a second ligand for CTLA-4 and CD28
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993) · Nature · doi:10.1038/366076a0 · Cited by 909
Signals and signs for lymphocyte responses
Janeway, C. A., & Bottomly, K. (1994) · Cell · doi:10.1016/0092-8674(94)90335-2 · Cited by 848
Yoshimoto, T., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1285 · Cited by 841
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.87 · Cited by 828
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Walker, L. S. K., & Sansom, D. M. (2011) · Nature Reviews Immunology · doi:10.1038/nri3108 · Cited by 786
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M. G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.19 · Cited by 777
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.
De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J., Leo, O., & Moser, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1413 · Cited by 762
Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells
Ridge, J. P., Fuchs, E. J., & Matzinger, P. (1996) · Science · doi:10.1126/science.271.5256.1723 · Cited by 760
Induction of Peripheral T Cell Tolerance In Vivo Requires CTLA-4 Engagement
Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B., & Abbas, A. K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80284-8 · Cited by 716
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P., & Hodes, R. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.631 · Cited by 669
Self-citationTreatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 668
Self-citationHow B and T cells talk to each other
Clark, E. A., & Ledbetter, J. A. (1994) · Nature · doi:10.1038/367425a0 · Cited by 641
Self-citationIMMUNE REGULATION BY CD40 AND ITS LIGAND GP39
Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E., & Noelle, R. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.591 · Cited by 626
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
Abrams, J. R., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Goldfarb, M. T., Goffe, B. S., Menter, A., Lowe, N. J., Krueger, G., Brown, M. J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5857 · Cited by 597
Self-citationLenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C., & Bluestone, J. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1145 · Cited by 583
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C., & Damle, N. K. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1595 · Cited by 581
Self-citationRanheim, E. A., & Kipps, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.925 · Cited by 580
Haslett, P. A. J., Corral, L. G., Albert, M., & Kaplan, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1885 · Cited by 573
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S., & Gordon, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11102 · Cited by 533
Self-citationEndocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, L.-S., Barroso-Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 532
The CD28-Related Molecule ICOS Is Required for Effective T Cell–Dependent Immune Responses
Coyle, A. J., Lehar, S., Lloyd, C., Tian, J., Delaney, T., Manning, S., Nguyen, T., Burwell, T., Schneider, H., Gonzalo, J. A., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00011-x · Cited by 520
Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation
Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P., & Hodes, R. J. (1993) · Science · doi:10.1126/science.7694361 · Cited by 517
Self-citationNew perspectives of C1328-137-mediated T cell costimulation
Bluestone, J. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90000-4 · Cited by 513
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
Sayegh, M. H., Akalin, E., Hancock, W. W., Russell, M. E., Carpenter, C. B., Linsley, P. S., & Turka, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1869 · Cited by 511
Self-citationLin, H., Bolling, S. F., Linsley, P. S., Wei, R. Q., Gordon, D., Thompson, C. B., & Turka, L. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1801 · Cited by 485
Self-citationHan, S., Hathcock, K., Zheng, B., Kepler, T. B., Hodes, R., & Kelsoe, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.556 · Cited by 480
Suthanthiran, M., & Strom, T. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310606 · Cited by 469
Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L., & Hafler, D. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1985 · Cited by 463
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellström, I., & Hellström, K. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.523 · Cited by 462
Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A., & Linsley, P. S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.165 · Cited by 461
Self-citationPrevention of Collagen-Induced Arthritis with an Antibody to gp39, the Ligand for CD40
Durie, F. H., Fava, R. A., Foy, T. M., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · Science · doi:10.1126/science.7689748 · Cited by 457
Self-citationDistinct Roles for LFA-1 and CD28 during Activation of Naive T Cells: Adhesion versus Costimulation
Bachmann, M. F., McKall-Faienza, K., Schmits, R., Bouchard, D., Beach, J., Speiser, D. E., Mak, T. W., & Ohashi, P. S. (1997) · Immunity · doi:10.1016/s1074-7613(00)80376-3 · Cited by 418
Coyle, A. J., & Gutierrez-Ramos, J.-C. (2001) · Nature Immunology · doi:10.1038/85251 · Cited by 413
Chambers, C. A., Sullivan, T. J., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80406-9 · Cited by 411
EFFECTS OF EXPLOSIVE BRAIN DEATH ON CYTOKINE ACTIVATION OF PERIPHERAL ORGANS IN THE RAT1
Takada, M., Nadeau, K. C., Hancock, W. W., Mackenzie, H. S., Shaw, G. D., Waaga, A. M., Chandraker, A., Sayegh, M. H., & Tilney, N. L. (1998) · Transplantation · doi:10.1097/00007890-199806270-00001 · Cited by 399
Absence of B7-dependent responses in CD28-deficient mice
Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G. S., Bluestone, J. A., & Thompson, C. B. (1994) · Immunity · doi:10.1016/1074-7613(94)90092-2 · Cited by 376
CTLA-4: a negative regulator of autoimmune disease.
Karandikar, N. J., Vanderlugt, C. L., Walunas, T. L., Miller, S. D., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.783 · Cited by 376
Uncovering of Functional Alternative CTLA-4 Counter-Receptor in B7-Deficient Mice
Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L., Lombard, D. B., et al. (1993) · Science · doi:10.1126/science.7694362 · Cited by 359
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
Guinan, E., Gribben, J., Boussiotis, V., Freeman, G., & Nadler, L. (1994) · Blood · doi:10.1182/blood.v84.10.3261.3261 · Cited by 358
Kubin, M., Kamoun, M., & Trinchieri, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.211 · Cited by 358
The role of the PD‐1 pathway in autoimmunity and peripheral tolerance
Fife, B. T., & Pauken, K. E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05919.x · Cited by 355
Foy, T. M., Shepherd, D. M., Durie, F. H., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1567 · Cited by 348
Self-citationCaux, C., Vanbervliet, B., Massacrier, C., Azuma, M., Okumura, K., Lanier, L. L., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1841 · Cited by 346
Ina, K., Itoh, J., Fukushima, K., Kusugami, K., Yamaguchi, T., Kyokane, K., Imada, A., Binion, D. G., Musso, A., West, G. A., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.1081 · Cited by 345
Cooke, M. P., Heath, A. W., Shokat, K. M., Zeng, Y., Finkelman, F. D., Linsley, P. S., Howard, M., & Goodnow, C. C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.425 · Cited by 333
Self-citationSelf-Tolerance Checkpoints in B Lymphocyte Development
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60633-1 · Cited by 328
Cathepsin S activity regulates antigen presentation and immunity.
Riese, R. J., Mitchell, R. N., Villadangos, J. A., Shi, G. P., Palmer, J. T., Karp, E. R., De Sanctis, G. T., Ploegh, H. L., & Chapman, H. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1158 · Cited by 321
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
Miller, S. D., Vanderlugt, C. L., Lenschow, D. J., Pope, J. G., Karandikar, N. J., Dal Canto, M. C., & Bluestone, J. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90063-2 · Cited by 315
Mechanism of cellular rejection in transplantation
Ingulli, E. (2010) · Pediatric Nephrology · doi:10.1007/s00467-008-1020-x · Cited by 313
CD28-B7 interactions in T-cell activation
Allison, J. P. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90120-1 · Cited by 313
ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2
Weber, J. P., Fuhrmann, F., Feist, R. K., Lahmann, A., Al Baz, M. S., Gentz, L.-J., Vu Van, D., Mages, H. W., Haftmann, C., Riedel, R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141432 · Cited by 295
Stüber, E., & Strober, W. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.979 · Cited by 286
ICOS is critical for T helper cell–mediated lung mucosal inflammatory responses
Gonzalo, J. A., Tian, J., Delaney, T., Corcoran, J., Rottman, J. B., Lora, J., Al-garawi, A., Kroczek, R., Gutierrez-Ramos, J. C., & Coyle, A. J. (2001) · Nature Immunology · doi:10.1038/89739 · Cited by 279
CD86 and CD80 Differentially Modulate the Suppressive Function of Human Regulatory T Cells
Zheng, Y., Manzotti, C. N., Liu, M., Burke, F., Mead, K. I., & Sansom, D. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2778 · Cited by 279
Magistrelli, G., Jeannin, P., Herbault, N., Benoit de Coignac, A., Gauchat, J.-F., Bonnefoy, J.-Y., & Delneste, Y. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3596::aid-immu3596>3.0.co;2-y · Cited by 276
Tan, J. T., Whitmire, J. K., Ahmed, R., Pearson, T. C., & Larsen, C. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4859 · Cited by 259
Expression and functional significance of an additional ligand for CTLA-4.
Lenschow, D. J., Su, G. H., Zuckerman, L. A., Nabavi, N., Jellis, C. L., Gray, G. S., Miller, J., & Bluestone, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11054 · Cited by 259
CD80, CD86 and CD40 Provide Accessory Signals in a Multiple‐Step T‐Cell Activation Model
Van Gool, S. W., Vandenberghe, P., Boer, M. D., & Ceuppens, J. L. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00920.x · Cited by 257
A Native Soluble Form of CTLA-4
Oaks, M. K., Hallett, K. M., Penwell, R. T., Stauber, E. C., Warren, S. J., & Tector, A. J. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1649 · Cited by 256
Weinberg, A. D., Wegmann, K. W., Funatake, C., & Whitham, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1818 · Cited by 252
Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L., & Kitsis, R. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145186 · Cited by 237
(1997) · PubMed · Cited by 105
Targeting Memory T Cells in Type 1 Diabetes
Ehlers, M. R., & Rigby, M. R. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0659-5 · Cited by 40
Metadata
- Authors
- Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., & Tepper, M. A.
- Venue
- Science
- Published
- 1992-08-07
- Volume
- 257
- Issue
- 5071
- Pages
- 792-795
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2037374883
- Cited by
- 790
- References
- 22
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.